488 related articles for article (PubMed ID: 24531836)
1. The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases.
Magna M; Pisetsky DS
Mol Med; 2014 Mar; 20(1):138-46. PubMed ID: 24531836
[TBL] [Abstract][Full Text] [Related]
2. The role of HMGB1 in inflammatory skin diseases.
Satoh TK
J Dermatol Sci; 2022 Aug; 107(2):58-64. PubMed ID: 35907655
[TBL] [Abstract][Full Text] [Related]
3. Redox modifications of cysteine residues regulate the cytokine activity of HMGB1.
Yang H; Lundbäck P; Ottosson L; Erlandsson-Harris H; Venereau E; Bianchi ME; Al-Abed Y; Andersson U; Tracey KJ
Mol Med; 2021 Jun; 27(1):58. PubMed ID: 34098868
[TBL] [Abstract][Full Text] [Related]
4. High-mobility group box-1 in sterile inflammation.
Tsung A; Tohme S; Billiar TR
J Intern Med; 2014 Nov; 276(5):425-43. PubMed ID: 24935761
[TBL] [Abstract][Full Text] [Related]
5. HMGB1 and leukocyte migration during trauma and sterile inflammation.
Venereau E; Schiraldi M; Uguccioni M; Bianchi ME
Mol Immunol; 2013 Aug; 55(1):76-82. PubMed ID: 23207101
[TBL] [Abstract][Full Text] [Related]
6. High Mobility Group Box Protein 1 (HMGB1): The Prototypical Endogenous Danger Molecule.
Yang H; Wang H; Chavan SS; Andersson U
Mol Med; 2015 Oct; 21 Suppl 1(Suppl 1):S6-S12. PubMed ID: 26605648
[TBL] [Abstract][Full Text] [Related]
7. Non-oxidizable HMGB1 induces cardiac fibroblasts migration via CXCR4 in a CXCL12-independent manner and worsens tissue remodeling after myocardial infarction.
Di Maggio S; Milano G; De Marchis F; D'Ambrosio A; Bertolotti M; Palacios BS; Badi I; Sommariva E; Pompilio G; Capogrossi MC; Raucci A
Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2693-2704. PubMed ID: 28716707
[TBL] [Abstract][Full Text] [Related]
8. The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis.
Yang H; Antoine DJ; Andersson U; Tracey KJ
J Leukoc Biol; 2013 Jun; 93(6):865-73. PubMed ID: 23446148
[TBL] [Abstract][Full Text] [Related]
9. HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease.
Harris HE; Andersson U; Pisetsky DS
Nat Rev Rheumatol; 2012 Jan; 8(4):195-202. PubMed ID: 22293756
[TBL] [Abstract][Full Text] [Related]
10. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.
Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M
Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436
[TBL] [Abstract][Full Text] [Related]
11. HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4.
Schiraldi M; Raucci A; Muñoz LM; Livoti E; Celona B; Venereau E; Apuzzo T; De Marchis F; Pedotti M; Bachi A; Thelen M; Varani L; Mellado M; Proudfoot A; Bianchi ME; Uguccioni M
J Exp Med; 2012 Mar; 209(3):551-63. PubMed ID: 22370717
[TBL] [Abstract][Full Text] [Related]
12. Oxidation of the alarmin high-mobility group box 1 protein (HMGB1) during apoptosis.
Urbonaviciute V; Meister S; Fürnrohr BG; Frey B; Gückel E; Schett G; Herrmann M; Voll RE
Autoimmunity; 2009 May; 42(4):305-7. PubMed ID: 19811284
[TBL] [Abstract][Full Text] [Related]
13. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release.
Yang H; Hreggvidsdottir HS; Palmblad K; Wang H; Ochani M; Li J; Lu B; Chavan S; Rosas-Ballina M; Al-Abed Y; Akira S; Bierhaus A; Erlandsson-Harris H; Andersson U; Tracey KJ
Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11942-7. PubMed ID: 20547845
[TBL] [Abstract][Full Text] [Related]
14. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE.
Urbonaviciute V; Fürnrohr BG; Meister S; Munoz L; Heyder P; De Marchis F; Bianchi ME; Kirschning C; Wagner H; Manfredi AA; Kalden JR; Schett G; Rovere-Querini P; Herrmann M; Voll RE
J Exp Med; 2008 Dec; 205(13):3007-18. PubMed ID: 19064698
[TBL] [Abstract][Full Text] [Related]
15. Redox-active trace metal-induced release of high mobility group box 1(HMGB1) and inflammatory cytokines in fibroblast-like synovial cells is Toll-like receptor 4 (TLR4) dependent.
Alsousi AA; Igwe OJ
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3847-3858. PubMed ID: 30254017
[TBL] [Abstract][Full Text] [Related]
16. Tumor cells express and maintain HMGB1 in the reduced isoform to enhance CXCR4-mediated migration.
Pirani E; Paparoditis P; Pecoraro M; Danelon G; Thelen M; Cecchinato V; Uguccioni M
Front Immunol; 2024; 15():1358800. PubMed ID: 38803493
[TBL] [Abstract][Full Text] [Related]
17. High mobility group box 1 in the pathogenesis of inflammatory and autoimmune diseases.
Voll RE; Urbonaviciute V; Herrmann M; Kalden JR
Isr Med Assoc J; 2008 Jan; 10(1):26-8. PubMed ID: 18300566
[TBL] [Abstract][Full Text] [Related]
18. Redox-Mediated Mechanisms Fuel Monocyte Responses to CXCL12/HMGB1 in Active Rheumatoid Arthritis.
Cecchinato V; D'Agostino G; Raeli L; Nerviani A; Schiraldi M; Danelon G; Manzo A; Thelen M; Ciurea A; Bianchi ME; Rubartelli A; Pitzalis C; Uguccioni M
Front Immunol; 2018; 9():2118. PubMed ID: 30283452
[TBL] [Abstract][Full Text] [Related]
19. β-Arrestin1 and β-Arrestin2 Are Required to Support the Activity of the CXCL12/HMGB1 Heterocomplex on CXCR4.
D'Agostino G; Artinger M; Locati M; Perez L; Legler DF; Bianchi ME; Rüegg C; Thelen M; Marchese A; Rocchi MBL; Cecchinato V; Uguccioni M
Front Immunol; 2020; 11():550824. PubMed ID: 33072091
[TBL] [Abstract][Full Text] [Related]
20. Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1).
Yang H; Lundbäck P; Ottosson L; Erlandsson-Harris H; Venereau E; Bianchi ME; Al-Abed Y; Andersson U; Tracey KJ; Antoine DJ
Mol Med; 2012 Mar; 18(1):250-9. PubMed ID: 22105604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
